Top Markets
#1 TENDIES TENDIES +30.92%
#2 Songbird Songbird +15.55%
#3 Pons Pons +14.35%
#4 MarsCoin MarsCoin +11.55%
#5 DAPPOS DAPPOS +11.44%
#6 Cryptopia Cryptopia +9.23%
#7 Biconomy Biconomy +7.58%
#8 Lista DAO Lista DAO +7.50%
#9 Seeker Seeker +7.41%
#10 Prom Prom +7.08%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Clasificación en acciones #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Precio por acción
$0.84484795
Última sincronización: 2026-08-28
Capitalización bursátil
$892.08M
Cambio (1 día)
-4.11%
Cambio (1 año)
27.37%
País
CN
Comercio Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Categoría

Healthcare
Ganancias de Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Chongqing Lummy Pharmaceutical Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Chongqing Lummy Pharmaceutical Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US